ArticlePloS one2014

Persistent release of IL-1s from skin is associated with systemic cardio-vascular disease, emaciation and systemic amyloidosis: the potential of anti-IL-1 therapy for systemic inflammatory diseases.

Keiichi Yamanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.